Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics

LinksSchließen

Referenz

Mora PAR, Sun SY, Velarde GC. et al.
Can carboplatin or etoposide replace actinomycin-d for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia?.

Gynecol Oncol 2019;
153 (02) 277-285
DOI: 10.1016/j.ygyno.2019.03.005.

Bibliographische Angaben herunterladen

Aufrufen in: